Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participants
Morgan A. Casal, S. Percy Ivy, Jan H. Beumer, Thomas D. Nolin
Topics & Concepts
DosingRenal functionMedicineCancerRace (biology)Clinical trialAnticancer drugDrugPhase (matter)Internal medicineOncologyIntensive care medicinePharmacologyChemistryBiologyOrganic chemistryBotanyRenal cell carcinoma treatmentChemotherapy-induced organ toxicity mitigationStatistical Methods in Clinical Trials